Efficacy and safety of methionine aminopeptidase 2 inhibition in type 2 diabetes: a randomised, placebo-controlled clinical trial. https://t.co/lPwbjSNVhq
Efficacy and safety of methionine aminopeptidase 2 inhibition in type 2 diabetes: a randomised, placebo-controlled clinical trial. https://t.co/xJNJG3tCnm
RT @profsmarshall: Up front & free to read in September's @DiabetologiaJnl: Efficacy and safety of methionine aminopeptidase 2 inhibition…
RT @profsmarshall: Up front & free to read in September's @DiabetologiaJnl: Efficacy and safety of methionine aminopeptidase 2 inhibition…
Venous thromboembolism will be the limiting factor...
RT @profsmarshall: Up front & free to read in September's @DiabetologiaJnl: Efficacy and safety of methionine aminopeptidase 2 inhibition…
Up front & free to read in September's @DiabetologiaJnl: Efficacy and safety of methionine aminopeptidase 2 inhibition in type 2 diabetes: a randomised, placebo-controlled clinical trial by Joseph Proietto et al #editorspicks https://t.co/Flu1GVezxl
First generation MetAP2 inhibition #diabetes Lessons from Beloranib @Zafgen https://t.co/mj5NlGrYeW